Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Everolimus|DRUG: Placebo|DRUG: Trastuzumab|DRUG: Paclitaxel
Sponsor: Novartis Pharmaceuticals